Dose-Response Effect of Baclofen in Reducing Daily Alcohol Intake in Alcohol Dependence: Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial, Alcohol and Alcoholism, vol.46, issue.3, pp.312-319, 2011. ,
DOI : 10.1093/alcalc/agr017
Alcohol-attributable mortality in France, The European Journal of Public Health, vol.23, issue.4, pp.588-93, 2013. ,
DOI : 10.1093/eurpub/ckt015
Effectiveness and Safety of Baclofen in the Treatment of Alcohol Dependent Patients, CNS & Neurological Disorders - Drug Targets, vol.9, issue.1, pp.33-44, 2010. ,
DOI : 10.2174/187152710790966614
Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings, Biochemical Pharmacology, vol.75, issue.1, pp.34-56, 2008. ,
DOI : 10.1016/j.bcp.2007.08.005
Suppression de la d??pendance ?? l???alcool et de la consommation d???alcool par le baclof??ne ?? haute dose??: un essai en ouvert, Annales M??dico-psychologiques, revue psychiatrique, vol.168, issue.2, pp.159-62, 2010. ,
DOI : 10.1016/j.amp.2009.12.008
Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study, The Lancet, vol.370, issue.9603, pp.1915-1937, 2007. ,
DOI : 10.1016/S0140-6736(07)61814-5
Acamprosate Produces Its Anti-Relapse Effects Via Calcium, Neuropsychopharmacology, vol.231, issue.4, pp.783-91, 2014. ,
DOI : 10.1038/npp.2013.264
Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection, Addictive Behaviors, vol.37, issue.4, pp.561-565, 2012. ,
DOI : 10.1016/j.addbeh.2011.12.010
Clinical effectiveness of baclofen for the treatment of alcohol dependence: a review, Clin Pharmacol Adv Appl, vol.5, pp.99-107, 2013. ,
Baclofen for Alcohol Dependence: A Preliminary Open-Label Study, Alcoholism: Clinical & Experimental Research, vol.12, issue.10, pp.1517-1540, 2004. ,
DOI : 10.1111/j.1360-0443.1989.tb00737.x
Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence, Alcohol Clin Exp Res, vol.24, issue.1, pp.67-71, 2000. ,
Baclofène : vérités et promesses d'un « nouveau » venu dans le traitement de l'alcoolodépendance, Alcoologie Addictologie, vol.32, issue.2, pp.119-143, 2010. ,
The clinical significance of drug craving, Annals of the New York Academy of Sciences, vol.79, issue.Suppl. 1, pp.1-17, 2012. ,
DOI : 10.1111/j.1749-6632.2011.06298.x
BACLOFEN EFFICACY IN REDUCING ALCOHOL CRAVING AND INTAKE: A PRELIMINARY DOUBLE-BLIND RANDOMIZED CONTROLLED STUDY, Alcohol and Alcoholism, vol.37, issue.5, pp.504-512, 2002. ,
DOI : 10.1093/alcalc/37.5.504
Efficacy and Safety of Baclofen for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial, Alcoholism: Clinical and Experimental Research, vol.12, issue.11, pp.1849-57, 2010. ,
DOI : 10.1111/j.1530-0277.2010.01273.x
Abstinence and 'Low-Risk' Consumption 1 Year after the Initiation of High-Dose Baclofen: A Retrospective Study among 'High-Risk' Drinkers, Alcohol and Alcoholism, vol.47, issue.4, pp.439-481, 2012. ,
DOI : 10.1093/alcalc/ags028
Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions, Arch Gen Psychiatry, issue.8, pp.61807-61823, 2004. ,
Baclofen for alcohol withdrawal, Cochrane Database Syst Rev, vol.2, p.8502, 2013. ,
Effets indésirables du baclofène dans le traitement des addictions. Suivi national de pharmacovigilance : année 2012, Comité technique de pharmacovigilance du 16 avril 2013, CT N°012013023. Commandité par l'ANSM ,
Un dispositif de prescriptions hors-AMM : exemple du baclof??ne, Th??rapie, vol.65, issue.6, pp.511-519, 2010. ,
DOI : 10.2515/therapie/2010073
Cas d'exposition au baclofène : données des centres antipoison et de toxicovigilance, 2003. ,
Baclofen overdose: Defining the spectrum of toxicity, Emergency Medicine Australasia, vol.35, issue.1, pp.77-82, 2006. ,
DOI : 10.1016/S0196-0644(03)00600-0
Baclofène et alcool. Société française d'alcoologie, 2011. ,
Acute Interaction of Baclofen in Combination With Alcohol in Heavy Social Drinkers, Alcoholism: Clinical and Experimental Research, vol.33, issue.1, pp.19-30, 2009. ,
DOI : 10.1111/j.1530-0277.2008.00805.x
Caractérisation de la prescription et des effets du baclofène (Liorésal®), 2011. ,
Intérêts et limites à partir de 13 entretiens qualitatifs. Thèse présentée pour le diplôme d'état de docteur en médecine, 2011. ,
Craving and relapse measurement in alcoholism., Alcohol and Alcoholism, vol.34, issue.2, pp.254-60, 1999. ,
DOI : 10.1093/alcalc/34.2.254
The validity of the Hospital Anxiety and Depression Scale, Journal of Psychosomatic Research, vol.52, issue.2, pp.69-77, 2002. ,
DOI : 10.1016/S0022-3999(01)00296-3
A narrative review of the Beck Depression Inventory (BDI) and implications for its use in an alcohol-dependent population, Journal of Psychiatric and Mental Health Nursing, vol.60, issue.1, pp.19-30, 2010. ,
DOI : 10.1111/j.1365-2850.2009.01469.x
Profils de personnalité, états émotionnels et prise de risques chez les femmes, Thèse de doctorat en psychologie du sport, 2006. ,
Evaluation Dimensionnelle de l'impulsivité dans le trouble obsessionnel compulsif, Thèse de doctorat en psychologie cognitive. Université Lumière Lyon, 2002. ,
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale, Sleep, vol.14, issue.6, pp.540-545, 1991. ,
DOI : 10.1093/sleep/14.6.540
Efficacité du baclofène dans la stratégie de réduction des risques chez les patients alcoolo-dépendants, revue de la littérature et étude sur 81 patients suivis pendant 6 mois en ambulatoire. Thèse présentée pour le diplôme d'état de docteur en médecine, 2013. ,
A human laboratory pilot study with baclofen in alcoholic individuals, Pharmacology Biochemistry and Behavior, vol.103, issue.4, pp.784-91, 2013. ,
DOI : 10.1016/j.pbb.2012.11.013
Further Validation of the Obsessive-Compulsive Drinking Scale (OCDS): Relationship to Alcoholism Severity, American Journal on Addictions, vol.7, issue.1, pp.14-23, 1998. ,
DOI : 10.3109/10550499809034708
Clinical Experience with Baclofen in the Management of Alcohol-Dependent Patients with Psychiatric Comorbidity: A Selected Case Series, Alcohol and Alcoholism, vol.46, issue.6, pp.714-734, 2011. ,
DOI : 10.1093/alcalc/agr131
COMPLETE AND PROLONGED SUPPRESSION OF SYMPTOMS AND CONSEQUENCES OF ALCOHOL-DEPENDENCE USING HIGH-DOSE BACLOFEN: A SELF-CASE REPORT OF A PHYSICIAN, Alcohol and Alcoholism, vol.40, issue.2, pp.147-50, 2005. ,
DOI : 10.1093/alcalc/agh130
High-Dose Baclofen for Treatment-Resistant Alcohol Dependence, Journal of Clinical Psychopharmacology, vol.32, issue.2, pp.266-274, 2012. ,
DOI : 10.1097/JCP.0b013e31824929b2
Alcool et baclofène : Etude sur 132 patients suivis pendant un an en ambulatoire. Thèse présentée pour le diplôme d'état de docteur en médecine, 2011. ,
Baclofen for alcohol dependence in France: Incidence of treated patients and prescription patterns???A cohort study, European Neuropsychopharmacology, vol.24, issue.2, pp.192-201, 2014. ,
DOI : 10.1016/j.euroneuro.2013.09.008
Baclofen for alcoholism, The Lancet, vol.370, issue.9603, pp.1884-1889, 2007. ,
DOI : 10.1016/S0140-6736(07)61789-9
The Obsessive Compulsive Drinking Scale, Archives of General Psychiatry, vol.53, issue.3, pp.225-256, 1996. ,
DOI : 10.1001/archpsyc.1996.01830030047008
Role of the GABAB receptor system in alcoholism and stress: focus on clinical studies and treatment perspectives, Alcohol, vol.43, issue.7, pp.559-63, 2009. ,
DOI : 10.1016/j.alcohol.2009.09.031
Increased Ethanol Consumption Following Chronic Psychosocial Stress: Do Oxytocin and Baclofen Hold any Therapeutic Promise?, Frontiers in Psychiatry, vol.4, p.148, 2013. ,
DOI : 10.3389/fpsyt.2013.00148
Baclofen administration for the treatment of affective disorders in alcoholic patients, Drug and Alcohol Dependence, vol.33, issue.2, pp.157-63, 1993. ,
DOI : 10.1016/0376-8716(93)90057-W
Substitution therapy for alcoholism: time for a reappraisal?, Journal of Psychopharmacology, vol.23, issue.8294, pp.205-217, 2012. ,
DOI : 10.1177/0269881111408463
Patient alcoolodépendant : sevrage et accompagnement post sevrage. Service d'hépatogastroentérologie et d'alcoologie du CHU de Bordeaux ,
Safety and Efficacy of Baclofen in the Treatment of Alcohol-Dependent Patients, Current Pharmaceutical Design, vol.16, issue.19, pp.2113-2120, 2010. ,
DOI : 10.2174/138161210791516440
Effets indésirables du baclofène dans le traitement des addictions, Suivi national de Pharmacovigilance : année 2011. Comité technique de Pharmacovigilance de mars 2012. Commandité par l'ANSM ,
High Variability in the Exposure of Baclofen in Alcohol-Dependent Patients, Alcoholism: Clinical and Experimental Research, vol.12, issue.2, pp.316-337, 2014. ,
DOI : 10.1111/acer.12235